In a similar fashion, another group also observed the ability of METTL3-mediated m6A to promote the expression of an oncogene (CDCP1) that together could promote malignant transformation and the progression of BLCA in vitro and in vivo [84]. The gene discussed is METTL3; the disease is bladder transitional cell carcinoma.